Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-12-28
1985-07-30
Love, Ethel G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C07D40500
Patent
active
045323275
ABSTRACT:
A novel alkaloid compound named "sesbanimide" has been isolated from the tissue of a leguminous plant known as Sesbania drummondii. Sesbanimide is characterized by the structural formula ##STR1## and is effective as an antineoplastic agent in animals.
REFERENCES:
patent: 3882124 (1975-05-01), Kirchlechner et al.
patent: 4200639 (1980-04-01), Powell
patent: 4279902 (1981-07-01), Hauck et al.
Kinoshita et al., Abstract No. 75, 185th ACS National Meeting, Mar. 20-25, 1983.
R. G. Powell et al., "Antitumor Activity of Sesbania vesicaria, S. punicea, and S. drummondii Seed Extracts," Planta Med. 30(1): 1-8, (Aug. 1976).
R. G. Powell et al., "An Investigation of the Antitumor Activity of Sesbania drummondii," J. Nat. Prod. 44(1): 86-90, (Jan.-Feb. 1981).
"Sesbanimide-A New Antitumor Compound," Northern Regional Research Center (NRRC) Notes from the Director, Issue #1531, (Jan. 14, 1983).
R. G. Powell et al., "Sesbanimide, A Potent Antitumor Substance from Sesbania drummondii Seed," Abstract #74, Abstracts of Papers, 185th ACS National Meeting, Seattle, WA., Mar. 20-25, 1983.
R. G. Powell et al., "Sesbanimide, A Potent Antitumor Substance from Sesbania drummondii Seed," J. Amer. Chem. Soc. 105(11): 3739-3741, (1983).
R. G. Powell et al., "Sesbanimide," Proceedings of Symposium on Discovery and Development of Naturally Occurring Antitumor Agents, Frederick, MD., Jun. 27-29, 1983.
Powell Richard G.
Smith, Jr. Cecil R.
Love Ethel G.
McConnell David G.
Ribando Curtis P.
Silverstein M. Howard
The United States of America as represented by the Secretary of
LandOfFree
Sesbanimide and the use thereof in treating leukemic tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sesbanimide and the use thereof in treating leukemic tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sesbanimide and the use thereof in treating leukemic tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2374101